Ruane Cunniff & Goldfarb L.P. Invests $190.90 Million in Align Technology, Inc. $ALGN

Posted by Stanley Muller on Jun 13th, 2026

Ruane Cunniff & Goldfarb L.P. acquired a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,222,534 shares of the medical equipment provider’s stock, valued at approximately $190,899,000. Align Technology comprises 3.0% of Ruane Cunniff & Goldfarb L.P.’s portfolio, making the stock its 15th biggest holding. Ruane Cunniff & Goldfarb L.P. owned 1.70% of Align Technology at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Dana Investment Advisors Inc. purchased a new stake in Align Technology during the third quarter valued at $9,991,000. AIA Group Ltd purchased a new stake in Align Technology during the third quarter valued at $2,507,000. Sequoia Financial Advisors LLC increased its position in Align Technology by 320.1% during the fourth quarter. Sequoia Financial Advisors LLC now owns 7,986 shares of the medical equipment provider’s stock valued at $1,247,000 after acquiring an additional 6,085 shares during the last quarter. Clarkston Capital Partners LLC increased its position in Align Technology by 25.7% during the third quarter. Clarkston Capital Partners LLC now owns 141,215 shares of the medical equipment provider’s stock valued at $17,683,000 after acquiring an additional 28,850 shares during the last quarter. Finally, M&G PLC purchased a new stake in Align Technology during the third quarter valued at $10,904,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

NASDAQ:ALGN opened at $174.84 on Friday. The stock has a 50-day simple moving average of $172.98 and a two-hundred day simple moving average of $170.60. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $208.30. The firm has a market capitalization of $12.52 billion, a PE ratio of 29.34, a P/E/G ratio of 1.81 and a beta of 1.67.

Align Technology (NASDAQ:ALGN – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.26 by $0.32. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the company posted $2.13 earnings per share. Align Technology’s revenue for the quarter was up 6.2% on a year-over-year basis. Equities analysts forecast that Align Technology, Inc. will post 9.48 earnings per share for the current fiscal year.

Align Technology announced that its board has initiated a stock buyback plan on Wednesday, April 29th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to buy up to 1.6% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Wall Street Zen cut Align Technology from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Barclays upgraded Align Technology from an “equal weight” rating to an “overweight” rating and set a $200.00 price objective for the company in a research report on Tuesday, March 17th. Weiss Ratings cut Align Technology from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, June 4th. Zacks Research upgraded Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, June 1st. Finally, Morgan Stanley upped their price objective on Align Technology from $169.00 to $188.00 and gave the company an “equal weight” rating in a research report on Friday, April 24th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $205.85.

Read Our Latest Stock Analysis on Align Technology

Align Technology Company Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.